MXPA03007123A - Formas cristalinas de derivado de nucleosido de pirimidina. - Google Patents

Formas cristalinas de derivado de nucleosido de pirimidina.

Info

Publication number
MXPA03007123A
MXPA03007123A MXPA03007123A MXPA03007123A MXPA03007123A MX PA03007123 A MXPA03007123 A MX PA03007123A MX PA03007123 A MXPA03007123 A MX PA03007123A MX PA03007123 A MXPA03007123 A MX PA03007123A MX PA03007123 A MXPA03007123 A MX PA03007123A
Authority
MX
Mexico
Prior art keywords
crystal
pyrimidine nucleoside
nucleoside derivative
crystalline forms
derivative
Prior art date
Application number
MXPA03007123A
Other languages
English (en)
Spanish (es)
Inventor
Takashi Takita
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of MXPA03007123A publication Critical patent/MXPA03007123A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
MXPA03007123A 2001-02-09 2002-02-06 Formas cristalinas de derivado de nucleosido de pirimidina. MXPA03007123A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001033128 2001-02-09
PCT/JP2002/000986 WO2002064609A1 (en) 2001-02-09 2002-02-06 Crystal of pyrimidine nucleoside derivative

Publications (1)

Publication Number Publication Date
MXPA03007123A true MXPA03007123A (es) 2003-11-18

Family

ID=18896929

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03007123A MXPA03007123A (es) 2001-02-09 2002-02-06 Formas cristalinas de derivado de nucleosido de pirimidina.

Country Status (21)

Country Link
EP (1) EP1364959B1 (enExample)
JP (2) JP3748536B2 (enExample)
KR (1) KR100679904B1 (enExample)
CN (1) CN100408591C (enExample)
AT (1) ATE361929T1 (enExample)
AU (1) AU2002230164B2 (enExample)
BR (2) BR0207102A (enExample)
CA (1) CA2437994C (enExample)
CY (1) CY1106685T1 (enExample)
CZ (1) CZ303241B6 (enExample)
DE (1) DE60220024T2 (enExample)
DK (1) DK1364959T3 (enExample)
ES (1) ES2286237T3 (enExample)
HU (1) HU229294B1 (enExample)
IL (2) IL157216A0 (enExample)
MX (1) MXPA03007123A (enExample)
NZ (1) NZ527393A (enExample)
PT (1) PT1364959E (enExample)
RU (1) RU2256666C2 (enExample)
WO (1) WO2002064609A1 (enExample)
ZA (1) ZA200306121B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019149A1 (en) 1999-09-02 2001-03-15 Ibiden Co., Ltd. Printed wiring board and method of producing the same and capacitor to be contained in printed wiring board
WO2001019148A1 (fr) 1999-09-02 2001-03-15 Ibiden Co., Ltd. Carte de circuit imprime et procede de fabrication associe
GB0526419D0 (en) * 2005-12-23 2006-02-08 Cyclacel Ltd Formulation
GB0625283D0 (en) 2006-12-19 2007-01-24 Cyclacel Ltd Combination
JP5066737B2 (ja) * 2007-04-06 2012-11-07 大鵬薬品工業株式会社 シチジン誘導体を含有する持続静脈内投与用抗腫瘍剤
US8124593B2 (en) 2007-11-05 2012-02-28 Cyclacel Limited Methods of treatment using sapacitabine
GB0808357D0 (en) * 2008-05-08 2008-06-18 Cyclacel Ltd Process
US8530445B2 (en) 2008-06-09 2013-09-10 Cyclacel Limited Combinations of sapacitabine or CNDAC with DNA methyltransferase inhibitors such as decitabine and procaine
US10226478B2 (en) 2011-04-14 2019-03-12 Cyclacel Limited Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid leukemia
ES2880109T3 (es) 2012-03-15 2021-11-23 Celgene Car Llc Formas sólidas de un inhibidor de la cinasa del receptor del factor de crecimiento epidérmico
KR102629310B1 (ko) 2015-03-09 2024-01-24 더블유.알. 그레이스 앤드 캄파니-콘. 니코틴아미드 리보사이드의 결정 형태
CN112020363A (zh) 2017-12-22 2020-12-01 益力舒健康公司 烟酰胺核苷氯化物的结晶形式

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2559917B2 (ja) * 1990-06-15 1996-12-04 三共株式会社 ピリミジンヌクレオシド誘導体
RU2085557C1 (ru) * 1991-09-30 1997-07-27 Санкио Компани Лимитед Производные нуклеозидов пиримидина или их фармацевтически приемлемые соли и способ их получения

Also Published As

Publication number Publication date
PT1364959E (pt) 2007-07-23
AU2002230164B2 (en) 2005-04-07
HUP0303159A3 (en) 2007-06-28
HUP0303159A2 (hu) 2003-12-29
EP1364959A1 (en) 2003-11-26
JP2002308895A (ja) 2002-10-23
ZA200306121B (en) 2005-01-26
BRPI0207102A8 (pt) 2018-02-27
CZ20032111A3 (cs) 2003-12-17
DE60220024D1 (en) 2007-06-21
ES2286237T3 (es) 2007-12-01
BR0207102A (pt) 2004-01-27
JP2006008699A (ja) 2006-01-12
DK1364959T3 (da) 2007-06-04
RU2003124648A (ru) 2005-02-27
JP4356998B2 (ja) 2009-11-04
KR20030081424A (ko) 2003-10-17
DE60220024T2 (de) 2007-11-22
KR100679904B1 (ko) 2007-02-07
CA2437994A1 (en) 2002-08-22
CY1106685T1 (el) 2012-05-23
HU229294B1 (en) 2013-10-28
ATE361929T1 (de) 2007-06-15
IL157216A (en) 2008-03-20
CN100408591C (zh) 2008-08-06
EP1364959B1 (en) 2007-05-09
CN1501939A (zh) 2004-06-02
RU2256666C2 (ru) 2005-07-20
EP1364959A4 (en) 2004-03-24
CA2437994C (en) 2011-05-17
IL157216A0 (en) 2004-02-19
WO2002064609A1 (en) 2002-08-22
NZ527393A (en) 2004-07-30
CZ303241B6 (cs) 2012-06-13
JP3748536B2 (ja) 2006-02-22

Similar Documents

Publication Publication Date Title
CY1106685T1 (el) Κρυσταλλος παραγωγου πυριμιδινο νουκλεοζιτη
IL160872A0 (en) Pyrimidinones as melanin concentrating hormone receptor 1
PT1448853E (pt) Melhoramentos relacionados com branqueadores ópticos
ZA200309887B (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
WO2001019828A3 (en) Kinase inhibitors as therapeutic agents
MA28172A1 (fr) 5,7-diaminopyrazolo [4,3-D] pyrimidines à activité inhibitrice de PDE-5
BR0210030A (pt) Derivado de fenilpiridinacarbonilpiperazina
WO2004046118A3 (en) 2-4-(di-phenyl-amino)-pyrimidine derivatives useful for treating hyper-proliferative disorders
CY1111759T1 (el) Ενδιαμεσες ενωσεις για την παρασκευη συγκεκριμενων τριαζολοπυριμιδινων ως ρ2τ ανταγωνιστων
AU2003229953A8 (en) Phthalazinone derivatives
PL369530A1 (en) Chemical compounds
IS8825A (is) Ný kristölluð og myndlaus form af tríasól (4,5-D) pýrimídínefnasambandi
CY1106132T1 (el) Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου
YU57603A (sh) Inhibitori fosfodiesteraze 4
MXPA02004440A (es) Derivados de pirrol como inhibidores de la fosfodiesterasa vii.
EP2251319A3 (en) Process for preparing derivatives of benzoic acid
SE0103710D0 (sv) Compounds
MXPA03009602A (es) Analogos de nociceptina.
CA2452036A1 (en) 6-'2-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity
WO2004002990A3 (en) Synthesis of purine derivatives
EP0924199A4 (enExample)
HU9904634D0 (en) New thiaazolidine-derivatives
DOP2002000371A (es) Fenil-heterociclil-eteres
BR0313976A (pt) Compostos de 7-fenilpirazolopiridina

Legal Events

Date Code Title Description
FG Grant or registration